China Leads Pharmaceutical Growth In 2009: Asia Pharma R&D Leaders
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - While China's most influential meeting - the eleventh National People's Congress of China - prepares to open its third session in Beijng March 5, pharma R&D leaders gathered in Shanghai to discuss the future of the pharmaceutical industry
You may also be interested in...
China's Big Cities Should Be First Priority For Pharma Companies - IMS
SHANGHAI- China's largest cities control the majority of the Chinese pharma market, and companies must decide city-specific sales strategies, according to the global healthcare data provider and consulting firm IMS Health
China's Big Cities Should Be First Priority For Pharma Companies - IMS
SHANGHAI- China's largest cities control the majority of the Chinese pharma market, and companies must decide city-specific sales strategies, according to the global healthcare data provider and consulting firm IMS Health
AstraZeneca Will Validate siRNA Delivery Technology For MDRNA In Shanghai Innovation Center
SHANGHAI - Bothell, Washington-headquartered MDRNA announced recently that the company will collaborate with AstraZeneca to validate MDRNA's small interfering RNA (siRNA) technology for systemic delivery in hepatocellular carcinoma, one of the company's preclinical oncology programs